BACKGROUND: The association between tumor complexity and postoperative complications after partial nephrectomy (PN) has not been well characterized. OBJECTIVE: We evaluated whether increasing renal tumor complexity, quantitated by nephrometry score (NS), is associated with increased complication rates following PN using the Clavien-Dindo classification system (CCS). DESIGN, SETTING, AND PARTICIPANTS: We queried our prospectively maintained kidney cancer database for patients undergoing PN from 2007 to 2010 for whom NS was available. INTERVENTIONS: All patients underwent PN. MEASUREMENTS: Tumors were categorized into low- (NS: 4-6), moderate- (NS: 7-9), and high-complexity (NS: 10-12) lesions. Complication rates within 30 d were graded (CCS: I-5), stratified as minor (CCS: I or 2) or major (CCS: 3-5), and compared between groups. RESULTS AND LIMITATIONS: A total of 390 patients (mean age: 58.0 ± 11.9 yr; 66.9% male) undergoing PN (44.6% open, 55.4% robotic) for low- (28%), moderate- (55.6%), and high-complexity (16.4%) tumors (mean tumor size: 3.74 ± 2.4 cm; median: 3.2 cm) from 2007 to 2010 were identified. Tumor size, estimated blood loss, and ischemia time all significantly differed (p<0.0001) between groups; patient age, body mass index (BMI), and operative time were comparable. When stratified by CCS, minor and major complication rates for all patients were 26.7% and 11.5%, respectively. Minor complication rates were comparable (26.6 vs. 24.9 vs 32.8%; p=0.45), whereas major complication rates differed (6.4 vs. 11.1 vs. 21.9%; p=0.009) among tumor complexity groups. Controlling for age, gender, BMI, type of surgical approach, operative duration, and tumor complexity, prolonged operative time (odds ratio [OR]: 1.01; confidence interval [CI], 1.0-1.02) and high tumor complexity (OR: 5.4; CI, 1.2-24.2) were associated with the postoperative development of a major complication. Lack of external validation is a limitation of this study. CONCLUSIONS: Increasing tumor complexity is associated with the development of major complications after PN. This association should be validated externally and integrated into the decision-making process when counseling patients with complex renal tumors.
BACKGROUND: The association between tumor complexity and postoperative complications after partial nephrectomy (PN) has not been well characterized. OBJECTIVE: We evaluated whether increasing renal tumor complexity, quantitated by nephrometry score (NS), is associated with increased complication rates following PN using the Clavien-Dindo classification system (CCS). DESIGN, SETTING, AND PARTICIPANTS: We queried our prospectively maintained kidney cancer database for patients undergoing PN from 2007 to 2010 for whom NS was available. INTERVENTIONS: All patients underwent PN. MEASUREMENTS: Tumors were categorized into low- (NS: 4-6), moderate- (NS: 7-9), and high-complexity (NS: 10-12) lesions. Complication rates within 30 d were graded (CCS: I-5), stratified as minor (CCS: I or 2) or major (CCS: 3-5), and compared between groups. RESULTS AND LIMITATIONS: A total of 390 patients (mean age: 58.0 ± 11.9 yr; 66.9% male) undergoing PN (44.6% open, 55.4% robotic) for low- (28%), moderate- (55.6%), and high-complexity (16.4%) tumors (mean tumor size: 3.74 ± 2.4 cm; median: 3.2 cm) from 2007 to 2010 were identified. Tumor size, estimated blood loss, and ischemia time all significantly differed (p<0.0001) between groups; patient age, body mass index (BMI), and operative time were comparable. When stratified by CCS, minor and major complication rates for all patients were 26.7% and 11.5%, respectively. Minor complication rates were comparable (26.6 vs. 24.9 vs 32.8%; p=0.45), whereas major complication rates differed (6.4 vs. 11.1 vs. 21.9%; p=0.009) among tumor complexity groups. Controlling for age, gender, BMI, type of surgical approach, operative duration, and tumor complexity, prolonged operative time (odds ratio [OR]: 1.01; confidence interval [CI], 1.0-1.02) and high tumor complexity (OR: 5.4; CI, 1.2-24.2) were associated with the postoperative development of a major complication. Lack of external validation is a limitation of this study. CONCLUSIONS: Increasing tumor complexity is associated with the development of major complications after PN. This association should be validated externally and integrated into the decision-making process when counseling patients with complex renal tumors.
Authors: Sompol Permpongkosol; Richard E Link; Li-Ming Su; Frederico R Romero; Herman S Bagga; Christian P Pavlovich; Thomas W Jarrett; Louis R Kavoussi Journal: J Urol Date: 2007-02 Impact factor: 7.450
Authors: Steven C Campbell; Andrew C Novick; Arie Belldegrun; Michael L Blute; George K Chow; Ithaar H Derweesh; Martha M Faraday; Jihad H Kaouk; Raymond J Leveillee; Surena F Matin; Paul Russo; Robert G Uzzo Journal: J Urol Date: 2009-08-14 Impact factor: 7.450
Authors: Inderbir S Gill; Louis R Kavoussi; Brian R Lane; Michael L Blute; Denise Babineau; J Roberto Colombo; Igor Frank; Sompol Permpongkosol; Christopher J Weight; Jihad H Kaouk; Michael W Kattan; Andrew C Novick Journal: J Urol Date: 2007-05-11 Impact factor: 7.450
Authors: Jonathan C Routh; Douglas R Bacon; Bradley C Leibovich; Horst Zincke; Michael L Blute; Igor Frank Journal: BJU Int Date: 2008-04-11 Impact factor: 5.588
Authors: S Machele Donat; Ahmad Shabsigh; Caroline Savage; Angel M Cronin; Bernard H Bochner; Guido Dalbagni; Harry W Herr; Matthew I Milowsky Journal: Eur Urol Date: 2008-07-14 Impact factor: 20.096
Authors: R Houston Thompson; Matt Kaag; Andrew Vickers; Shilajit Kundu; Melanie Bernstein; William Lowrance; David Galvin; Guido Dalbagni; Karim Touijer; Paul Russo Journal: J Urol Date: 2009-01-16 Impact factor: 7.450
Authors: Zhuo-Wei Liu; Ephrem O Olweny; Gang Yin; Stephen Faddegon; Yung K Tan; Woong Kyu Han; Jeffrey A Cadeddu Journal: World J Urol Date: 2012-04-28 Impact factor: 4.226
Authors: J-P Couapel; K Bensalah; J-C Bernhard; G Pignot; L Zini; H Lang; J Rigaud; L Salomon; L Bellec; M Soulié; C Vaessen; M Rouprêt; J-L Jung; E Mourey; P Bigot; F Bruyère; J Berger; J-P Ansieau; P Gimel; F Salome; J Hubert; C Pfister; H Baumert; M-O Timsit; A Méjean; J J Patard Journal: World J Urol Date: 2013-11-24 Impact factor: 4.226
Authors: Massimiliano Spaliviero; Bing Ying Poon; Christoph A Karlo; Giuliano B Guglielmetti; Pier Luigi Di Paolo; Renato Beluco Corradi; Alexandre G Martin-Malburet; Felix Campos-Juanatey; Eva Escudero-Fontano; Daniel D Sjoberg; Paul Russo; Jonathan A Coleman; Oguz Akin; Karim A Touijer Journal: Eur Urol Date: 2015-08-20 Impact factor: 20.096
Authors: Scott E Eggener; Melanie A Clark; Sergey Shikanov; Benjamin Smith; Matthew Kaag; Paul Russo; Jeffrey C Wheat; J Stuart Wolf; Surena F Matin; William C Huang; Miriam Harel; Joseph Cambio; Arieh L Shalhav; Jay D Raman Journal: World J Urol Date: 2014-05-10 Impact factor: 4.226
Authors: Tobias Klatte; Vincenzo Ficarra; Christian Gratzke; Jihad Kaouk; Alexander Kutikov; Veronica Macchi; Alexandre Mottrie; Francesco Porpiglia; James Porter; Craig G Rogers; Paul Russo; R Houston Thompson; Robert G Uzzo; Christopher G Wood; Inderbir S Gill Journal: Eur Urol Date: 2015-04-22 Impact factor: 20.096